Holdco Nuvo Group D.G Ltd. NUVOQ
- Market cap
- $2.1M
- P/E
- 0.0×
Follow NUVOQ
Target Price Range
Analyst price targets
Free account| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 9.72 | 9.41 |
Analyst estimates 2024–2026 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | 10.71 | 11.66 |
High Price
|
|||
| — | — | — | — | — | — | — | 3 | 3 | 59 |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | — | — | 0 |
Revenue
|
|||
| — | — | — | — | — | — | — | — | — | (8.52%) |
Gross Margin
|
|||
| — | — | — | — | — | — | — | (34) | (20) | (35) |
EBT
|
|||
| — | — | — | — | — | — | — | 0.00% | 0.00% | (19,712.50%) |
EBT Margin
|
|||
| — | — | — | 0 | — | — | — | (35) | (21) | (34) |
Net Income
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Depreciation
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.01 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | (2.03) | (1.21) | (1.86) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | (0.85) | (0.79) | (0.83) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | (0.01) | (0.01) | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | (0.86) | (0.81) | (0.83) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | (0.51) | (2.27) | (3.74) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | 17 | 17 | 18 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | — | — | 0.00 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | — | — | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | — | — | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | — | — | (13.73) |
EV/FCF
|
|||
| — | — | — | — | — | — | — | (14) | (13) | (15) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Capex
|
|||
| — | — | — | — | — | — | — | (15) | (14) | (15) |
FCF
|
|||
| — | — | — | — | — | — | — | 1 | (39) | (29) |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | 9 | 12 |
Total Debt
|
|||
| — | — | — | — | — | — | — | (1) | 8 | 11 |
Net Debt
|
|||
| — | — | — | — | — | — | — | (9) | (39) | (67) |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | (13.15%) | (15.36%) | (930.47%) |
ROA
|
|||
| — | — | — | — | — | — | — | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | (28.67%) | (19.42%) | 63.38% |
ROE
|
|||
Holdco Nuvo Group D.G Ltd. peers in Medical Devices
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| BIOLQ Biolase, Inc. | $2.3M | 0.0× | Compare |
| AFIB Acutus Medical, Inc. | $1.7M | 0.0× | Compare |
| PFSA PROFUSA, Inc. | $1.6M | 0.0× | Compare |
| DHAI DIH Holding US, Inc. | $1.6M | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NUWE Nuwellis, Inc. | $2.9M | 0.0× | Compare |
| VTAK Catheter Precision, Inc. | $3.0M | 0.0× | Compare |
| XAIR Beyond Air, Inc. | $3.1M | 0.0× | Compare |
| TNON Tenon Medical, Inc. | $3.2M | 0.0× | Compare |
Holdco Nuvo Group D.G Ltd. (NUVOQ) key facts
- Holdco Nuvo Group D.G Ltd. (NUVOQ) is a Medical Devices company in the Healthcare sector.
- Holdco Nuvo Group D.G Ltd.’s revenue for fiscal 2023 (year ended December 2023) was $176,000.00.
- Return on equity was 63.4% and debt-to-equity -0.17.
Holdco Nuvo Group D.G Ltd. (NUVOQ) Latest News
4 Sep
US Bankruptcy Court imposes restrictions on trading in equity interests in Holdco Nuvo Group D.G Ltd. and affiliates. The court order imposing restrictions on trading in equity interests is a significant event that could fundamentally alter the company's trajectory and investor sentiment.
9 May
Nuvo Group appoints Adriana Machado to its board of directors to enhance its mission of improving pregnancy care through remote monitoring technology. The addition of a seasoned health and impact expert like Adriana Machado is expected to significantly strengthen Nuvo's strategic direction and market impact.
1 May
Nuvo Group Ltd. completes business combination with LAMF Global Ventures Corp. to become a public company, trading on NASDAQ under ticker symbol NUVO. The completion of the business combination and access to capital markets are expected to significantly impact Nuvo's future growth and market performance.
12 Apr
LAMF Global Ventures Corp. I extends deadline for business combination. The extension of the deadline for the business combination may moderately influence the company's financial performance and competitive positioning.
2 Apr
LAMF Global Ventures Corp. I shareholders approve business combination with Nuvo Group Ltd. The approved business combination is expected to significantly impact LGVC's future market performance and strategic direction.
26 Mar
LAMF Global Ventures Corp. I intends to adjourn extraordinary general meeting of shareholders until April 1, 2024. The adjournment of the meeting may moderately influence the company's future business combination with Nuvo Group Ltd.
12 Feb
LAMF Global Ventures Corp. I extends deadline for business combination. The extension of the deadline may moderately influence the company's future performance and market positioning.
8 Jan
LAMF Global Ventures Corp. I extends deadline for business combination to February 16, 2024. The extension of the deadline may moderately influence the company's future performance.
18 Aug
Nuvo Group Ltd. to merge with LAMF Global Ventures Corp. I, creating a public company on Nasdaq with a focus on pregnancy care technology. The merger with Nuvo Group Ltd. is a significant strategic move that is expected to have a profound influence on LGVC's future and market performance.